Key result
Reduced DLCO/VA predicts ~50% higher mortality in advanced heart failure.
Why the study?
Little is known about how lung function relates to central haemodynamics in patients with congestive heart failure and reduced LVEF.
Does reduced pulmonary diffusion capacity (DLCO/VA) predict mortality and correlate with central haemodynamics in patients with advanced heart failure?
Cohort (n=262)
Does reduced pulmonary diffusion capacity (DLCO/VA) predict mortality and correlate with central haemodynamics in patients with advanced heart failure?
Hazard Ratio: 1.5 (95% CI 1.1–2.1)
In patients with advanced heart failure, pulmonary diffusion capacity correlates positively with left ventricular filling pressures, and reduced DLCO/VA independently predicts mortality.
May support DLCO/VA for prognostication in advanced HF; leaves open incremental value over standard models and need for prospective validation.
Aims Patients with heart failure (HF) are known to have a reduced pulmonary diffusion capacity for carbon monoxide (DLCO), but little is known about how lung function relates to central haemodynamics. The aim of this study was to investigate the association between haemodynamic variables and pulmonary diffusion capacity adjusted for alveolar volume in congestive HF patients and to analyse how predicted DLCO/VA affects mortality in relation to the haemodynamic status. Methods and results We retrospectively studied right heart catheterization (RHC) and lung function data on 262 HF patients (mean age 51 ± 13 years) with a left ventricular ejection fraction < 45% referred non-urgently for evaluation for heart transplantation (HTX) or left ventricular assist device (LVAD). Univariate and multivariate linear regression models were constructed to examine the associations between predicted values of DLCO/VA, forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1), and haemodynamic parameters [pulmonary capillary wedge pressure (PCWP), central venous pressure, cardiac index, mean pulmonary artery pressure, and mean arterial pressure] as well as other factors known to affect lung function in HF. FEV1 was reduced to <80% of predicted value in 55% of the population, and DLCO/VA was reduced in 63% of the population. DLCO/VA correlated positively with pulmonary capillary wedge pressure in both univariate and multivariate analyses for all included patients (P < 0.001 and P = 0.045, respectively) and a restricted population of patients with the shortest time between RHC and lung function testing (P = 0.005, P = 0.015). DLCO/VA predicted mortality in multivariate models [hazard ratio 1.5 (1.1–2.1)] but not the combined endpoint of death, LVAD implantation, or HTX. There was no significant correlation between haemodynamics and predicted FVC or FEV1. Conclusions Pulmonary diffusion capacity correlates positively with left ventricular fillings pressures, and reduced values predict increased mortality in patients with HF. This might be driven by increased lung capillary volume in patients with pulmonary congestion.
No takes yet. Share an insight, caveat, or question.
Deis et al. (2019) conducted a cohort in Heart failure (n=262). Reduced pulmonary diffusion capacity (DLCO/VA) was evaluated on Mortality (HR 1.5, 95% CI 1.1-2.1). Reduced pulmonary diffusion capacity adjusted for alveolar volume (DLCO/VA) predicted increased mortality in patients with advanced heart failure (HR 1.5; 95% CI 1.1-2.1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: